Trial Profile
Pre-exposure prophylaxis implementation of emtricitabine/tenofovir disoproxil fumarate for risk of sexually-transmitted HIV in France
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections; Sexually transmitted infections
- Focus Adverse reactions; Therapeutic Use
- 24 Sep 2018 Results published in the AIDS.
- 31 Aug 2017 New trial record
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science